3,491
Participants
Start Date
February 28, 2003
Primary Completion Date
January 31, 2005
Study Completion Date
January 31, 2005
Clopidogrel (SR25990)
plus acetylsalicylic acid (ASA)
Placebo
plus acetylsalicylic acid (ASA)
Sanofi-Aventis, Bridgewater
Sanofi-Aventis, Buenos Aires
Sanofi-Aventis, Macquarie Park
sanofi-aventis Austria, Vienna
sanofi-aventis Belgium, Diegem
sanofi-aventis Brazil, São Paulo
sanofi-aventis Canada, Laval
sanofi-aventis France, Paris
sanofi-aventis Germany, Berlin
Sanofi-Aventis Hungaria, Budapest
Sanofi-Aventis, Dublin
Sanofi-Aventis, Netanya
sanofi-aventis Italy, Milan
Sanofi-Aventis Mexico, México
sanofi-aventis Netherlands, Gouda
sanofi-aventis Poland, Warsaw
Sanofi-Aventis, Porto
Sanofi-Aventis, San Juan
Sanofi-Aventis, Moscow
sanofi-aventis South Africa, Midrand
sanofi-aventis Spain, Barcelona
sanofi-aventis Sweden, Bromma
Sanofi-Aventis, Istanbul
sanofi-aventis UK, Guildford
Lead Sponsor
Collaborators (1)
Bristol-Myers Squibb
INDUSTRY
Sanofi
INDUSTRY